top of page

Main Partner and Investor

Partnering structure : 

  • Strategic equity investment  

  • Onward Therapeutics is the majority shareholder of Emercell


Emercell works in collaboration with Onward Therapeutics a development stage oncology company, focusing on the identification of innovative technologies and the development of truly breakthrough medicines for the treatment of cancer.

Other Partners

bottom of page